Bridgeway Capital Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CCM
GCM
RIM
KCM
SCA
Bridgeway Capital Management's LMAT Position: Q4 2021 in Review
Bridgeway Capital Management sold out of LeMaitre Vascular (LMAT) in Q4 2021, closing a stake of 7,600 shares — an estimated $403K sold.
Bridgeway Capital Management first reported a position in LMAT in Q2 2013 and held it in 17 quarters. The position peaked at $866K in Q4 2015. 183 funds tracked by Wall St. Rank hold LMAT as of Q4 2021.
- Bridgeway Capital Management reported no remaining LeMaitre Vascular position as of Q4 2021 after selling out during the quarter.
- Bridgeway Capital Management sold 7,600 LeMaitre Vascular shares in Q4 2021, an estimated $403K.
- Bridgeway Capital Management first reported a position in LeMaitre Vascular in Q2 2013 and held it in 17 quarters.
- Bridgeway Capital Management's LeMaitre Vascular position peaked at $866K in Q4 2015.
- 183 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2021.
Based on Bridgeway Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.